AUTL Autolus Therapeutics Ltd

USD 2.94 0.10 ( (3.52%))
Icon

Autolus Therapeutics Ltd (AUTL) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 2.94

+0.10 (+3.52)%

USD 0.78B

1.64M

USD 10.10(+243.54%)

N/A

Icon

AUTL

Autolus Therapeutics Ltd (USD)
COMMON STOCK | NSD
USD 2.94
0.10 ( (3.52%))

Autolus Therapeutics Ltd (AUTL) Stock Forecast

Show ratings and price targets of :
USD 10.10
(+243.54%)

Based on the Autolus Therapeutics Ltd stock forecast from 4 analysts, the average analyst target price for Autolus Therapeutics Ltd is USD 10.10 over the next 12 months. Autolus Therapeutics Ltd’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Autolus Therapeutics Ltd is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, Autolus Therapeutics Ltd’s stock price was USD 2.94. Autolus Therapeutics Ltd’s stock price has changed by -4.55% over the past week, -33.78% over the past month and -34.38% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...